Funding · Company
Renibus Therapeutics, Inc.
Southlake, TXBiotech & Pharma
Renibus Therapeutics, Inc. of Southlake, TX has disclosed $169M across 3 Form D offerings filed with the SEC between Feb 18, 2022 and Jul 17, 2025.
$169M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$111M
Form D · Jul 17, 2025 ↗
Q3 2025
· 2 amendments, first filed Jun 9, 2023
$23M
Form D · Aug 22, 2022 ↗
Q3 2022
· 1 amendment, first filed Jul 29, 2022
· target $25M
Filing details
HeadquartersSouthlake, TXIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001667699Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →